Mutations in the non-structural protein 5A gene in patients with chronic hepatitis C virus 1b infection during repeated interferon treatment
スポンサーリンク
概要
- 論文の詳細を見る
- 2000-11-01
著者
-
IINO Shiro
Kiyokawa Hospital
-
IINO SHIRO
Department of Medicine, Seizankai Kiyokawa Hospital
-
Okuse Chiaki
Division Of Gastroenterology And Hepatology Department Of Internal Medicine St Marianna University S
-
SUGATA Fumihiko
Department of Internal Medicine, St. Marianna University School of Medicine
-
Iino S
Internal Medicine Kiyokawa Hospital
-
IINO Shiro
Internal Medicine, Kiyokawa Hospital
-
OKUSE Chiaki
Department of Internal Medicine, Division of Gastroenterology and Hepatology, St. Marianna Universit
-
IWABUCHI Shogo
Department of Internal Medicine, Division of Gastroenterology and Hepatology, St. Marianna Universit
-
Iino Shiro
Internal Medicine Kiyokawa Hospital
-
Iino S
Department Of Medicine Seizankai Kiyokawa Hospital
-
TAKATORI Masao
Department of Gastroenterology and Hepatology, St. Marianna University School of Medicine
-
Iino Shiro
Department Of Gastroenterology And Hepatology St. Marianna University Medical School
-
Iwabuchi Shogo
The Department Of Gastroenterology And Hepatology St. Marianna University School Of Medicine
-
Takatori Masao
The Department Of Internal Medicine Division Of Gastroenterology And Hepatology St. Marianna Univers
-
Iino Shiro
Department Of Medicine Seizankai Kiyokawa Hospital
-
Okuse Chiaki
Department Of Internal Medicine Division Of Gastroenterology And Hepatology St. Marianna University
-
Sugata Fumihiko
Department Of Gastroenterology And Hepatology St. Marianna University School Of Medicine
関連論文
- Membranous Nephropathy Associated with Chronic Hepatitis B Occurring in a Short Period After Acute Hepatitis B Virus Infection
- Effect of nucleoside analog-interferon sequential therapy on patients with acute exacerbation of chronic hepatitis B
- Spatial and chronological differences in hepatitis B virus genotypes from patients with acute hepatitis B in Japan
- Timing of interferon therapy and sources of infection in patients with acute hepatitis C
- Reactivation of hepatitis B virus in HBsAg-negative patients with multiple myeloma : two case reports
- Phase 1/2 clinical study of dasatinib in Japanese patients with chronic myeloid leukemia or Philadelphia chromosome-positive acute lymphoblastic leukemia
- Impact of daily high-dose IFNα-2b plus ribavirin combination therapy on reduction of ALT levels in patients with chronic hepatitis C with genotype 1 and high HCV RNA levels
- Prediction of treatment outcome with daily high-dose IFN α-2b plus ribavirin in patients with chronic hepatitis C with genotype 1b and high HCV RNA levels : relationship of baseline viral levels and viral dynamics during and after therapy
- A significant reduction in serum alanine aminotransferase levels after 3-month iron reduction therapy for chronic hepatitis C : a multicenter, prospective, randomized, controlled trial in Japan
- Pregnancy-Associated Cytotoxic Lymphoma: A Report of 4 Cases
- Detection of API2-MALT1 Fusion Transcripts in Cytologic Specimens of Patients with Pulmonary Mucosa-Associated Lymphoid Tissue Lymphoma
- MUM1/IRF4 Expression Is an Unfavorable Prognostic Factor in B-Cell Chronic Lymphocytic Leukemia(CLL)/Small Lymphocytic Lymphoma(SLL)
- Lineage Conversion from Acute Lymphoblastic Leukemia to Acute Myeloid Leukemia on Rearrangement of the IgH Gene in a Patient with Down Syndrome
- A Novel Cell Line of Acute Lymphoblastic Leukemia (ALL-L3, Burkitt's Type), NCU-L-3
- A case of complete necrosis of well-differentiated early hepatocellular carcinoma by percutaneous transhepatic portal embolization
- Hepatitis viral infection in Behcet's disease
- Serum HCV RNA levels during early phase of recombinant interferon alfa-2a (Roferon A) therapy for chronic hepatitis C and efficacy of short-term therapy with earlier loss of viremia
- Short-term prolongation of pegylated interferon and ribavirin therapy for genotype 1b chronic hepatitis C patients with early viral response
- Assessment of hepatic steatosis and hepatic tissue blood flow by xenon computed tomography in nonalcoholic steatohepatitis
- Effect of treatment with interferon α-2b and ribavirin in patients infected with genotype 2 hepatitis C virus
- Hepatitis C as a systemic disease : virus and host immunologic responses underlie hepatic and extrahepatic manifestations
- Amino acid substitutions in the S region of hepatitis B virus in sera from patients with acute hepatitis
- A case of deep venous thrombosis associated with pegylated interferon α2b plus ribavirin treatment of chronic hepatitis C
- Detection, using a novel method, of a high prevalence of cryoglobulinemia in persistent hepatitis C virus infection
- Serum lipid profile of patients with genotype 1b hepatitis C viral infection in Japan
- One-point quantitative determination of pretreatment serum hepatitis C virus RNA predicts long-term responsiveness to high-dose interferon therapy
- Intrahepatic hepatitis C virus RNA levels after interferon treatment: eradication of the minus-strand RNA correlates with sustained remission of hepatitis
- Bortezomib-induced apoptosis in mature T-cell lymphoma cells partially depends on upregulation of Noxa and functional repression of Mcl-1
- Overexpression of carboxylesterase-2 results in enhanced efficacy of topoisomerase I inhibitor, irinotecan (CPT-11), for multiple myeloma
- Frequent occurrence of CCND1 deregulation in patients with early stages of plasma cell dyscrasia
- Therapeutic effects of stronger neo-minophagen C at different doses on chronic hepatitis and liver cirrhosis
- Efficacy of interferon alfacon-1 daily induction therapy followed by three-times weekly therapy in patients with chronic hepatitis C virus infection with high and low viral titers
- Involvement of GBV-C/HGV in liver diseases in Japan
- T-Cell Acute Lymphoblastic Leukemia as a Secondary Leukemia after a 3-Year Remission of Acute Myelocytic Leukemia
- Lack of Ku80 Alteration in Multiple Myeloma
- Successful Treatment of Nasal T-Cell Lymphoma With a Combination of Local Irradiation and High-Dose Chemotherapy
- Superior Mesenteric Venous Thrombosis Associated With a Familial Missense Mutation (Pro626Leu) in the SHBG-Like Domain of the Protein S Molecule
- Ectopic Expression of MAFB Gene in Human Myeloma Cells Carrying (14;20)(q32;q11) Chromosomal Translocations
- Improvement of Splenomegaly and Pancytopenia by Enzyme Replacement Therapy Against Type 1 Gaucher Disease: A Report of Sibling Cases
- A Novel Human Multiple Myeloma-Derived Cell Line, NCU-MM-1, Carrying t(2;11)(p11;q23) and t(8;22)(q24;q11) Chromosomal Translocations With Overexpression of c-Myc Protein
- Multiple myeloma preceding the development of chronic myelogenous leukemia
- Sustained activation of c-jun-N-terminal kinase plays a critical role in arsenic trioxide-induced cell apoptosis in multiple myeloma cell lines
- Mutations in the non-structural protein 5A gene in patients with chronic hepatitis C virus 1b infection during repeated interferon treatment
- Amino acid mutations in the interferon sensitivity determining region and serum virus load in hepatitis C virus carriers with long-term normal ALT levels
- A randomized clinical trial with natural interferon-α monotherapy for 24 or 48 weeks on patients with chronic hepatitis C having genotype 1b infection in high viral titers
- Different hepatitis B virus genotype distributions among asymptomatic carriers and patients with liver diseases in Nanning, southern China
- Congenital Hepatic Fibrosis with Fatal Cholestatic Liver Damage
- Transcatheter Arterial Embolization for Impending Rupture of an Isolated Internal Iliac Artery Aneurysm Complicated with Disseminated Intravascular Coagulation
- Risk of Japanese carriers of hyperphosphorylated paratarg-7, the first autosomal-dominantly inherited risk factor for hematological neoplasms, to develop monoclonal gammopathy of undetermined significance and multiple myeloma
- Pathophysiological analysis of nonalcoholic fatty liver disease by evaluation of fatty liver changes and blood flow using xenon computed tomography : can early-stage nonalcoholic steatohepatitis be distinguished from simple steatosis?